Stay updated on Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page
- Check7 days agoChange DetectedThe page now displays a newer revision tag (v3.6.3) replacing the previous v3.6.0, indicating a minor backend/template update without altering study information.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now indicates recruitment is closed. It also adds new guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study, and updates the Intervention/Treatment area along with a revision label v3.6.0.SummaryDifference0.3%

- Check28 days agoChange DetectedA new revision entry (Revision: v3.5.5) has been added along with new dates (2026-06-03, 2026-12-18, 2026-05-08, 2026-05). The previous revision (v3.5.4) was removed, signaling an update to IPD sharing materials and related study documents.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now shows a new Revision: v3.5.4 tag replacing the previous v3.5.3, indicating a minor update to the document version. This reflects metadata refresh rather than substantive changes to the study details.SummaryDifference0.0%

- Check65 days agoChange DetectedThe Taiwan site listing changes from Taoyuan, Taiwan, 333 to Taoyuan City, Taiwan, 333. This clarifies the city designation in the Locations list, aiding accurate site identification and search filters.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page’s revision identifier was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor site/version update rather than a change to the underlying study information.SummaryDifference0.0%

Stay in the know with updates to Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.